RAISE: Collecting Better Data: Incentives, Framework, and Mission

Thursday, February 2, 2023

2-3 PM ET  

Incomplete and inconsistent capture of information about race and ethnicity in real-world data (RWD) limits a full understanding of the distribution, safety, and effectiveness of FDA-regulated products, which impacts the health of the public.

The Reagan-Udall Foundation for the FDA, in collaboration with FDA's Office of Minority Health and Health Equity, launched RAISE to elevate the capture and curation of race and ethnicity data in health care settings to ultimately improve the quality of health care and medical products.  

Read Speaker bios

Learn more about RAISE 

Read this Meeting Summary

Review all Meeting Summaries

AGENDA

2 PM Welcome 
         Speaker: Susan C. Winckler RPh, Esq, Reagan-Udall Foundation for the FDA

2:02 PM Welcome Remarks from FDA
         Speaker: RDML Richardae Araojo, PharmD, MS, U.S. Food and Drug Administration

2:05 PM Connecting the Dots: Incentives and Frameworks
         Speaker: Carla Rodriguez-Watson, PhD, MPH, Reagan-Udall Foundation for the FDA

2:07 PM Presentations 

              Better Healthcare Data on Race and Ethnicity Needed to Progress
              Clinical Trial Diversity 
              Leo J. Russo, PhD, Head of Global Medical Epidemiology 
               Pfizer, Inc.          

              The Role of Value-Based Payment in Advancing Health Equity 
               Kate de Lisle, Associate Principal, Payment & Delivery Transformation 
               Leavitt Partners, an HMA Company

2:35 PM Moderated Discussion 
              Moderator: Amy Abernethy, MD, PhD 
              President of Product Development and Chief Medical Officer
              Verily

             Discussants:     
             Citizen Voice: Yasmeen Long, MA, Milken Institute
             Robert Flemming, Lt Col, USAF, MSC
             Leo J. Russo, PhD
             Kate de Lisle

3 PM Adjourn

 
 
This project is supported by the Food and Drug Administration (FDA) Office of Minority Health and Health Equity of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award (FAIN) totaling $499,514 (100% funded by FDA OMHHE/HHS). The contents are those of the author(s) and do not necessarily represent the official views of nor an endorsement by FDA/HHS, or the U.S. Government.